From PKU to Genome Sequencing: The Past, Present, and Future of Newborn Screening
NBS has transformed over the past 6 decades from single-condition testing to complex, multi-disorder programs. While genomic technologies promise further expansion, careful evaluation of clinical, ethical, and practical considerations is essential to ensure that NBS continues to provide timely, equitable, and beneficial care to all newborns.
Authors
- Amber Nakar-Weinstein
- Yishay Ben-Moshe
- V Reid Sutton
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1093/clinchem/hvaf148
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00